Anti-Inflammatory Activity GHKCu has been shown in cell and animal models to lower key inflammatory signals, including TNFalpha and other proinflammatory cytokines such as IL6
The listing of a material on this website does not constitute a license to, or a recommendation for its use in infringement of any patent whatsoever
There is no validated human dosage, and no studies confirm injection safety in humans
It is prescribed for individuals with growth deficiencies, helping to stimulate growth and development in children
Preferred subcutaneous sites include the abdomen and the outer upper arms, providing straightforward access for individuals administering their own injections: Abdomen: Injections are given at least two inches away from the navel, allowing for a broad area of fat tissue
Dosing and administration Injectable therapeutic peptides normally come in a vial containing a months worth of medicine, requiring you to measure each injection according to your prescribers instructions